ABSTRACT
Background
Sepsis‐associated
encephalopathy
(SAE),
a
severe
neurological
disorder,
is
marked
by
widespread
brain
dysfunction.
At
present,
there
no
universally
accepted
criterion
for
diagnosing
SAE
in
animal
models.
This
study
proposes
standardized
evaluation
method
mice,
addressing
inconsistencies
current
research.
Method
Using
cecal
ligation
and
puncture
(CLP)
model
to
induce
sepsis,
we
assessed
the
physiological
status
of
mice
with
modified
SHIRPA
score
differentiate
from
non‐SAE,
validating
our
findings
through
various
behavioral
tests
evaluations
neuroinflammation
neuronal
damage.
Results
Our
revealed
that
conventional
mild–moderate–severe
categorization
was
insufficient
distinguishing
between
non‐SAE.
To
enhance
differentiation,
classified
based
on
median
score,
this
approach
including
Y‐maze,
three‐chamber
social
test,
open
field
test.
effectively
identified
impairments
septic
mice.
Further
validation
involved
assessing
damage,
neuroinflammation,
Morris
water
maze,
long‐term
potentiation
(LTP)
hippocampal
CA1
region.
indicated
up‐Median
group
exhibited
greater
injury,
cognitive
deficits
compared
down‐Median
group.
Conclusions
establishes
reliable
murine
models,
facilitating
improved
differentiation
Such
advancements
will
understanding
pathogenesis
guide
more
effective
treatment
strategies.
Journal of Neuroinflammation,
Journal Year:
2024,
Volume and Issue:
21(1)
Published: April 8, 2024
Abstract
Ischemic
stroke
is
the
leading
cause
of
adult
disability.
Ischemia
leads
to
progressive
neuronal
death
and
synapse
loss.
The
engulfment
stressed
synapses
by
microglia
further
contributes
disruption
surviving
network
related
brain
function.
Unfortunately,
there
currently
no
effective
target
for
suppressing
microglia-mediated
engulfment.
Stimulator
interferon
genes
(STING)
an
important
participant
in
innate
immune
response.
In
brain,
are
primary
cell
type
that
mediate
response
after
insult.
intimate
relationship
between
STING
neuroinflammation
has
been
gradually
established.
However,
whether
affects
other
functions
remains
elusive.
this
study,
we
found
regulated
microglial
phagocytosis
photothrombotic
stroke.
treatment
inhibitor
H151
significantly
improved
behavioral
performance
injured
mice
grid-walking
test,
cylinder
adhesive
removal
test
Moreover,
puncta
number
engulfed
SYP
or
PSD95
was
reduced
consecutive
administration.
Further
analysis
showed
mRNA
levels
several
complement
components
phagocytotic
receptors
were
decreased
inhibition.
Transcriptional
factor
STAT1
known
regulating
most
molecules.
After
inhibition,
nucleus
translocation
phosphorylated
also
suppressed
microglia.
Our
data
uncovered
novel
regulatory
effects
stroke,
emphasized
as
a
potential
drug-able
post-stroke
functional
recovery.
Cell & Bioscience,
Journal Year:
2024,
Volume and Issue:
14(1)
Published: April 1, 2024
Abstract
Background
Repeated
neonatal
sevoflurane
exposures
led
to
neurocognitive
disorders
in
young
mice.
We
aimed
assess
the
role
of
microglia
and
complement
C1q
sevoflurane-induced
neurotoxicity
explore
underlying
mechanisms.
Methods
Neonatal
mice
were
treated
with
on
postnatal
days
6,
8,
10,
Morris
water
maze
was
performed
cognitive
functions.
For
mechanistic
explorations,
minocycline,
C1q-antibody
ANX005,
sialidase-inhibitor
N-acetyl-2,3-dehydro-2-deoxyneuraminic
acid
(NADNA)
before
exposures.
Western
blotting,
RT-qPCR,
Golgi
staining,
3D
reconstruction
engulfment
analysis,
immunofluorescence,
microglial
morphology
analysis
performed.
In
vitro
experiments
conducted
cell
line
BV2
cells.
Results
resulted
deficiencies
learning
cognition
mice,
accompanied
by
activation
synapse
loss.
Sevoflurane
enhanced
microglia-mediated
elimination
through
binding
synapses.
Inhibition
phagocytosis
minocycline
significantly
reduced
loss
further
revealed
involvement
neuronal
sialic
acids
this
process.
The
activity
sialidase
acids,
which
facilitated
ANX005
or
inhibition
NADNA
rescued
improved
function.
cells,
reversed
ANX005.
Conclusions
Our
findings
demonstrated
that
C1q-mediated
synaptic
enhancing
desialylation
contributed
developmental
neurotoxicity.
may
be
a
potential
therapeutic
strategy
for
Molecular Therapy,
Journal Year:
2024,
Volume and Issue:
32(7), P. 2113 - 2129
Published: May 23, 2024
Sepsis-associated
encephalopathy
(SAE)
is
a
frequent
complication
of
severe
systemic
infection
resulting
in
delirium,
premature
death,
and
long-term
cognitive
impairment.
We
closely
mimicked
SAE
murine
peritoneal
contamination
(PCI)
model.
found
long-lasting
synaptic
pathology
the
hippocampus
including
defective
plasticity,
reduction
mature
neuronal
dendritic
spines,
severely
affected
excitatory
neurotransmission.
Genes
related
to
signaling,
gene
for
activity-regulated
cytoskeleton-associated
protein
(Arc/Arg3.1)
members
transcription-regulatory
EGR
family,
were
downregulated.
At
level,
ARC
expression
mitogen-activated
kinase
signaling
brain
affected.
For
targeted
rescue
we
used
adeno-associated
virus-mediated
overexpression
vivo.
This
recovered
plasticity
improved
memory
dysfunction.
Using
enriched
environment
paradigm
as
non-invasive
intervention,
improvement
potentiation,
memory,
anxiety.
The
beneficial
effects
an
accompanied
by
increase
brain-derived
neurotrophic
factor
(BDNF)
hippocampus,
suggesting
that
activation
BDNF-TrkB
pathway
leads
restoration
PCI-induced
ARC.
Collectively,
our
findings
identify
pathomechanisms
underlying
provide
conceptual
approach
target
SAE-induced
dysfunction
with
potential
therapeutic
applications
patients
SAE.
Frontiers in Immunology,
Journal Year:
2023,
Volume and Issue:
14
Published: Nov. 22, 2023
Microglia,
the
resident
macrophages
of
central
nervous
system
(CNS),
play
a
critical
role
in
CNS
homeostasis
and
neuroinflammation.
Pexidartinib
(PLX3397),
colony-stimulating
factor
1
(CSF1)
receptor
inhibitor,
is
widely
used
to
deplete
microglia,
offering
flexible
options
for
both
long-term
depletion
highly
versatile
depletion-repopulation
cycles.
However,
potential
impact
PLX3397
on
peripheral
(immune)
cells
remains
controversial.
Until
now,
microglia-specificity
this
type
compounds
has
not
been
thoroughly
evaluated,
particularly
context
peripherally
derived
Our
study
addresses
gap
by
examining
effects
immune
brain,
liver,
circulation
bone
marrow,
systemic
inflammation
models.
Intriguingly,
we
demonstrate
that
treatment
only
influences
levels
tissue-resident
macrophages,
but
also
affects
circulating
marrow
beyond
mononuclear
phagocyte
(MPS).
These
alterations
disrupt
response
inflammation,
consequently
impacting
phenotype
irrespective
microglial
depletion.
Furthermore,
observed
lower
dose
PLX3397,
which
does
demonstrates
similar
(non-)MPS
effects,
periphery
fails
fully
replicate
seen
higher
doses,
questioning
doses
as
‘peripheral
control’
strategy.
Overall,
our
data
highlight
need
caution
when
interpreting
studies
employing
compound,
it
may
be
suitable
specific
investigation
function
presence
inflammation.
Frontiers in Immunology,
Journal Year:
2024,
Volume and Issue:
15
Published: May 21, 2024
Sepsis
is
a
clinical
syndrome
caused
by
uncontrollable
immune
dysregulation
triggered
pathogen
infection,
characterized
high
incidence,
mortality
rates,
and
disease
burden.
Current
treatments
primarily
focus
on
symptomatic
relief,
lacking
specific
therapeutic
interventions.
The
core
mechanism
of
sepsis
believed
to
be
an
imbalance
in
the
host's
response,
early
excessive
inflammation
followed
late
suppression,
invasion.
This
suggests
that
we
can
develop
immunotherapeutic
treatment
strategies
targeting
modulating
components
immunological
functions
innate
adaptive
systems.
Therefore,
this
paper
reviews
mechanisms
and,
based
foundation,
discusses
current
state
immunotherapy
applications
animal
models
trials.
Advanced Science,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Aug. 1, 2024
Abstract
Ischemic
stroke
(IS)
is
a
leading
cause
of
morbidity
and
mortality
globally
triggers
series
reactions
to
primary
secondary
brain
injuries
permanent
neurological
deficits.
Microglia
in
the
central
nervous
system
play
dual
roles
neuroprotection
responding
ischemic
damage.
Here,
an
IS
model
employed
determine
involvement
microglia
phagocytosis
at
excitatory
synapses.
Additionally,
effects
pharmacological
depletion
are
investigated
on
improving
neurobehavioral
outcomes
mitigating
injury.
RNA
sequencing
reveals
increase
phagocytosis‐associated
pathway
activity
gene
expression,
C‐type
lectin
domain
family
7
member
A
(Clec7a)
identified
as
key
regulator
this
process.
Manipulating
microglial
Clec7a
expression
can
potentially
regulate
synapses,
thereby
preventing
synaptic
loss
after
IS.
It
further
demonstrat
that
interacts
with
neuronal
myeloid
differentiation
protein
2
(MD2),
molecule
mediating
poststroke
injury,
propose
novel
hypothesis
MD2
ligand
for
Clec7a.
These
findings
suggest
plays
critical
role
mouse
IS,
suggesting
may
be
therapeutic
target
Immunological Reviews,
Journal Year:
2024,
Volume and Issue:
327(1), P. 8 - 32
Published: Oct. 1, 2024
Neuroinflammation,
characterized
by
a
complex
interplay
among
innate
and
adaptive
immune
responses
within
the
central
nervous
system
(CNS),
is
crucial
in
responding
to
infections,
injuries,
disease
pathologies.
However,
dysregulation
of
neuroinflammatory
response
could
significantly
affect
neurons
terms
function
structure,
leading
profound
health
implications.
Although
tremendous
progress
has
been
made
understanding
relationship
between
processes
alterations
neuronal
integrity,
specific
implications
concerning
both
structure
have
not
extensively
covered,
with
exception
perspectives
on
glial
activation
neurodegeneration.
Thus,
this
review
aims
provide
comprehensive
overview
multifaceted
interactions
key
inflammatory
players,
exploring
mechanisms
through
which
inflammation
influences
functionality
structural
integrity
CNS.
Further,
it
will
discuss
how
these
lead
impairment
functions
architecture
highlight
consequences
caused
dysregulated
functions,
such
as
cognitive
dysfunction
mood
disorders.
By
integrating
insights
from
recent
research
findings,
enhance
our
landscape
set
stage
for
future
interventions
that
transform
current
approaches
preserve
CNS-related
conditions.